Clozapine is not a first generation antipsychotic. It is a second generation (atypical) antipsychotic, and in fact, it was the first drug in that category. Clozapine holds a unique place in psychiatry as the only medication with proven effectiveness for treatment-resistant schizophrenia, which is why it remains widely used despite requiring intensive safety monitoring.
Why Clozapine Is Classified as Second Generation
The distinction between first and second generation antipsychotics comes down to how each type interacts with the brain. First generation drugs, like haloperidol and chlorpromazine, work primarily by blocking dopamine receptors. They’re effective at reducing hallucinations and delusions, but that strong dopamine blockade also causes significant movement-related side effects: muscle stiffness, tremors, restlessness, and involuntary repetitive movements known as tardive dyskinesia.
Clozapine works differently. It has a relatively weak grip on dopamine receptors compared to first generation drugs, but a much stronger effect on serotonin receptors. This combination of strong serotonin blockade and weak dopamine blockade is the defining feature of second generation antipsychotics. It’s what allows clozapine to treat psychotic symptoms while causing far fewer movement side effects. In a landmark study published in the New England Journal of Medicine, patients on clozapine had less tardive dyskinesia and fewer movement-related side effects than those taking haloperidol, a classic first generation drug.
How First and Second Generation Drugs Compare
The terminology can be confusing because “generation” implies a clear timeline, and the reality is messier. Clozapine was actually synthesized in the 1960s, around the same time as many first generation drugs. What makes it “second generation” isn’t when it was discovered but how it works in the brain. Here’s a simplified comparison:
- First generation (typical): Strong dopamine blockade. Effective for positive symptoms like hallucinations. Higher risk of movement disorders and tardive dyskinesia. Examples include haloperidol and chlorpromazine.
- Second generation (atypical): Weaker dopamine blockade combined with stronger serotonin effects. Generally lower risk of movement side effects, but may cause metabolic issues like weight gain. Clozapine was the first in this class, followed later by risperidone, olanzapine, and others.
Neither generation is universally “better.” Each comes with trade-offs, and the choice depends on how a person responds to treatment and which side effects are most manageable for them.
What Makes Clozapine Unique
Even among second generation antipsychotics, clozapine stands apart. It is currently the only evidence-based treatment for treatment-resistant schizophrenia, a condition defined as having no significant improvement in symptoms after trying at least two different antipsychotic medications, each at an adequate dose for at least six weeks. Clinical guidelines recommend reevaluating the treatment plan after 12 weeks of nonresponse, at which point clozapine becomes the primary option.
Roughly 20 to 30 percent of people with schizophrenia don’t respond adequately to standard antipsychotic medications. For these individuals, clozapine often succeeds where other drugs have failed. No other antipsychotic, first or second generation, has matched its effectiveness in this population.
Required Blood Monitoring
The reason clozapine isn’t prescribed more broadly, despite its effectiveness, is a rare but serious side effect: it can cause a dangerous drop in white blood cells called agranulocytosis. A large Finnish study found that the cumulative incidence of agranulocytosis was about 1.4% for people taking clozapine, compared to 0.13% for those on other antipsychotics. That’s roughly ten times the risk, which is why clozapine requires a structured monitoring program.
If you’re prescribed clozapine, you’ll need regular blood draws to check your white blood cell counts. The schedule follows a stepwise pattern:
- First six months: Weekly blood tests
- Months six through twelve: Blood tests every two weeks, as long as counts stay in the normal range
- After twelve months: Monthly blood tests, continuing for as long as you take the medication
Normal thresholds vary slightly depending on individual factors. For the general population, the target white blood cell count is at or above 1,500 cells per microliter. For people with a condition called benign ethnic neutropenia, which naturally causes lower baseline counts and is more common in people of African and Middle Eastern descent, the threshold is adjusted to 1,000 or above.
Other Side Effects to Expect
While clozapine largely avoids the movement problems associated with first generation drugs, it carries its own set of side effects. Weight gain is common and sometimes substantial. It can also raise blood sugar and cholesterol levels, increasing metabolic risk over time. Sedation is another frequent effect, particularly when starting the medication or increasing the dose. Some people experience excessive salivation, especially at night, and constipation that can occasionally become severe if not managed.
The therapeutic blood level for clozapine falls between 350 and 600 nanograms per milliliter, measured as a trough level before the next dose. Levels at or above 1,000 are considered toxic. Your prescriber will sometimes check these levels to make sure the dose is in the right range, particularly if symptoms aren’t improving or side effects become difficult to manage.